デフォルト表紙
市場調査レポート
商品コード
1701114

アニマルヘルスの市場規模、シェア、成長分析:動物の種類別、製品の種類別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Animal Health Market Size, Share, and Growth Analysis, By Animal Type (Production Animals, Companion Animals), By Product Type (Biologics, Pharmaceuticals), By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
アニマルヘルスの市場規模、シェア、成長分析:動物の種類別、製品の種類別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アニマルヘルス市場規模は2023年に633億米ドルとなり、予測期間(2025~2032年)のCAGRは7.3%で、2024年の679億2,000万米ドルから2032年には1,193億4,000万米ドルに成長する見通しです。

アニマルヘルス市場は、家畜生産の増加と動物の病気に対する意識の高まりにより、大きな成長を遂げています。この分野には、コンパニオンアニマルと食用動物の両方の健康を確保することを目的としたワクチン、診断薬、抗生物質、デジタル技術など、さまざまな製品が含まれています。人間の疾病の約60%は人獣共通感染症であるため、動物用医薬品問題の効果的なモニタリングと予防の必要性が最も重要です。さらにこの業界は、遺伝学や薬物試験に動物を利用する生物学的研究において重要な役割を果たしています。規制基準が強化され、疾病予防が重視される中、高品質で革新的なアニマルヘルス製品に対する需要が急増し、すべてのセグメントで市場の急速な拡大が見込まれています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ

アニマルヘルス市場規模:動物の種類別

  • 市場概要
  • 生産動物
    • 家禽
    • 羊とヤギ
  • コンパニオンアニマル
    • その他

アニマルヘルス市場規模:製品の種類別

  • 市場概要
  • 生物学的製剤
    • ワクチン
    • 修正/減衰ライブ
    • 不活性化(殺傷)
    • その他のワクチン
    • その他の生物学的製剤
  • 医薬品
    • 寄生虫駆除剤
    • 抗感染薬
    • 抗炎症
    • 鎮痛剤
    • その他
  • 医薬品飼料添加物
  • 診断
    • 消耗品、試薬、キット
    • 器具および装置
  • 機器と使い捨て品
    • クリティカルケア消耗品
    • 麻酔機器
    • 体液管理装置
    • 温度管理装置
    • 救助・蘇生機器
    • 調査機器
    • 患者モニタリング機器
  • その他
    • 獣医遠隔医療
    • 獣医用ソフトウェア
    • 家畜監視

アニマルヘルス市場規模:流通チャネル別

  • 市場概要
  • 小売り
  • eコマース
  • 病院/クリニック薬局

アニマルヘルス市場規模:エンドユーザー別

  • 市場概要
  • 獣医リファレンスラボ
  • ポイントオブケア検査/院内検査
  • 動物病院・クリニック
  • その他

アニマルヘルス市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022~2024年)

主要企業プロファイル

  • Zoetis(USA)
  • Merck & Co.(USA)
  • Boehringer Ingelheim(Germany)
  • Elanco(USA)
  • IDEXX Laboratories(USA)
  • Virbac(France)
  • Bayer Animal Health(Germany)
  • Ceva Sante Animale(France)
  • Dechra Pharmaceuticals(UK)
  • Phibro Animal Health(USA)
  • Vetoquinol(France)
  • Norbrook Laboratories(UK)
  • Eco Animal Health(UK)
  • Krka(Slovenia)
  • Orion(Finland)
  • Animalcare Group(UK)
  • Sequent Scientific(India)
  • Venky's(India)
  • Hester Biosciences(India)
  • ImmuCell Corporation(USA)

結論と提言

目次
Product Code: SQMIG35D2005

Animal Health Market size was valued at USD 63.3 billion in 2023 and is poised to grow from USD 67.92 billion in 2024 to USD 119.34 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The animal health market is experiencing significant growth, driven by rising livestock production and increased awareness of animal diseases. This sector encompasses a variety of products, including vaccines, diagnostics, antibiotics, and digital technologies, aimed at ensuring the health of both companion and food animals. As approximately 60% of human diseases are zoonotic, the need for effective monitoring and prevention of animal health issues is paramount. Furthermore, the industry plays a crucial role in biological research, utilizing animals for genetics and drug testing. With heightened regulatory standards and a focus on disease prevention, the demand for high-quality and innovative animal health products is expected to surge, leading to rapid market expansion across all segments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Health Market Segments Analysis

Global Animal Health Market is segmented by Animal Type, Product Type, Distribution Channel, End User and region. Based on Animal Type, the market is segmented into Production Animals and Companion Animals. Based on Product Type, the market is segmented into Biologics, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables and Others. Based on Distribution Channel, the market is segmented into Retail, E-Commerce and Hospital/ ClinicPharmacy. Based on End User, the market is segmented into Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Health Market

The animal health market is expected to experience significant growth due to the rise in zoonotic diseases. As more individuals adopt pets as companions, the prevalence of diseases transmitted from animals to humans is increasing, highlighting the need for enhanced awareness and prevention strategies. This heightened awareness is essential, given that zoonotic diseases rank among the most contagious globally. Furthermore, the expanding array of therapeutic options is anticipated to bolster demand for veterinary care products in the near future. Collectively, these factors accentuate the importance of proactive measures to mitigate the risks associated with zoonotic infections, thereby driving market growth.

Restraints in the Animal Health Market

The growth of the Animal Health market may be hindered by stringent government regulations concerning drug approvals. In the United States, all veterinary drugs require approval from the Food and Drug Administration (FDA). The Animal Health Organization highlights that the development of a new veterinary drug can take up to ten years and incur costs exceeding $100 million. Similarly, creating a new vaccine typically requires three to five years and around $80 million before gaining approval. Additionally, manufacturers are obligated to contribute to the FDA approval process through user fees under the Animal Drug User Fee Act (ADUFA), adding another layer of complexity that may adversely affect the global animal health market during the forecast period.

Market Trends of the Animal Health Market

The Animal Health market is undergoing a significant tech-driven transformation, positioned for explosive growth and innovation. With advancements in gene editing, precision medicine, and digital health monitoring, the industry is anticipated to reach approximately US$ 12.6 billion by 2025, growing at a remarkable rate of 8.8%. Innovative solutions, including wearable devices that monitor vital signs and AI-powered diagnostic tools, are revolutionizing disease prevention, treatment, and recovery processes. These technologies are not just enhancing animal welfare but are also contributing to improved agricultural productivity, thereby expanding their impact across both farm and household settings. This trend underscores the increasing integration of technology in enhancing overall animal and crop health.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Animal Health Market Size by Animal Type & CAGR (2025-2032)

  • Market Overview
  • Production Animals
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Fish
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others

Global Animal Health Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Biologics
    • Vaccines
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
    • Other Biologics
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Others
  • Medicinal Feed Additives
  • Diagnostics
    • Consumables, reagents and kits
    • Instruments and devices
  • Equipment & Disposables
    • Critical Care Consumables
    • Anesthesia Equipment
    • Fluid Management Equipment
    • Temperature Management Equipment
    • Rescue & Resuscitation Equipment
    • Research Equipment
    • Patient Monitoring Equipment
  • Others
    • Veterinary Telehealth
    • Veterinary Software
    • Livestock Monitoring

Global Animal Health Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Retail
  • E-Commerce
  • Hospital/ Clinic Pharmacy

Global Animal Health Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Veterinary Reference Laboratories
  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

Global Animal Health Market Size & CAGR (2025-2032)

  • North America (Animal Type, Product Type, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Animal Type, Product Type, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Animal Type, Product Type, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Animal Type, Product Type, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Animal Type, Product Type, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Zoetis (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer Animal Health (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechra Pharmaceuticals (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phibro Animal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Norbrook Laboratories (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eco Animal Health (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Krka (Slovenia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orion (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Animalcare Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sequent Scientific (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Venky's (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hester Biosciences (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ImmuCell Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations